Findings

What do systematic reviews say?

10 questions · 10 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 40%Low 5 · 50%Moderate 1 · 10%High 0 · 0%

Antispasmodics vs control

Duration of 1st stage of labour · women in labour

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 1995 participants
Low

Antispasmodics vs control

Duration of second stage (minutes) · women in labour

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1297 participants
Low

Antispasmodics vs control

Duration of third stage of labour (min) · women in labour

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 765 participants
Low

Antispasmodics vs control

Total duration of labour minutes · women in labour

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 797 participants
Very low

Antispasmodics vs control

Rate of cervical dilatation (cm/h) · women in labour

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 820 participants
Low

Antispasmodics vs control

Rate of normal vertex deliveries · women in labour

Antispasmodics showed no clear difference in rate of normal vertex deliveries compared with control (moderate certainty).

1 finding from 1 review

Antispasmodics for labour 2013 · Cochrane Headline outcomes only
RR 1.02 [1, 1.05]
16 studies · 2319 participants
Moderate

Antispasmodics vs placebo

Pain duration (mean pain duration, assessed at 4 weeks) · Children with recurrent abdominal pain

It is very uncertain whether antispasmodics changes pain duration (mean pain duration, assessed at 4 weeks) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for recurrent abdominal pain in childhood 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 120 participants
Very low

Antispasmodics vs placebo

Pain improvement (clinician judged, assessed at 2 weeks) · Children with recurrent abdominal pain

It is very uncertain whether antispasmodics changes pain improvement (clinician judged, assessed at 2 weeks) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for recurrent abdominal pain in childhood 2017 · Cochrane Headline outcomes only
OR 3.33 [0.93, 12.01]
1 study · 42 participants
Very low

Antispasmodics vs placebo

Pain episodes · Children with recurrent abdominal pain

It is very uncertain whether antispasmodics changes pain frequency (episodes of pain in 4 weeks, assessed after 4 weeks) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for recurrent abdominal pain in childhood 2017 · Cochrane Headline outcomes only
MD 11.3 [2.4, 20.1]
1 study · 132 participants
Very low

Antispasmodics vs placebo

Pain improvement (self reported response to treatment, assessed at 4 weeks) · Children with recurrent abdominal pain

Antispasmodics showed no clear difference in pain improvement (self reported response to treatment, assessed at 4… compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for recurrent abdominal pain in childhood 2017 · Cochrane Headline outcomes only
OR 1.6 [0.7, 3.4]
1 study · 115 participants
Low